AB
Andson Biotech Inc.
SEC filingBiotechnology · Atlanta, GA
Amount raised$4.7Msold at filing
Total offering$5M$265K still open
Investors in the raise29count reported to the SEC
FiledOct 22, 2025first sale Oct 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrei FedorovDirector
Mason ChilmonczykExecutive Officer, Director
Jim FilippiniExecutive Officer
Thomas O'BrienDirector
Glenn EpsteinDirector
James RossDirector
Executive officers, directors and promoters as listed on the Form D.